Arcutis Gains FDA Approval for ZORYVE Cream in Children
Westlake Village, California, United States – March 10, 2026 Arcutis Biotherapeutics has announced that the U.S. Food and Drug...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Westlake Village, California, United States – March 10, 2026 Arcutis Biotherapeutics has announced that the U.S. Food and Drug...
SAN DIEGO, California | December 24, 2025 — Dermata Therapeutics, a science-driven dermatology-focused pharmaceutical company, announced a private placement...
